1[1]Harris NL, Jaffe ES, Diebold J,et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: report of the clinical advisory committee meeting-Airlie house,Virginia,November 1997 [J]. J Clin Oncol, 1999,17 (12):3835-3849.
2[2]Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: aprogress report [J].Am Soci Clin Pathol, 1999,111(1 Suppl 1):S8-S12.
3[3]Bennett JM. World Health Organization classification of the acute leukemias and myelodysplastic syndrome[J]. Int J Hematol, 2000, 72(2):131-133.
4[4]Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M]. IARC press, Lyon, 2001. 106-107.
5[5]Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms[J]. Blood, 2002, 100(7):2292-2302.
1Houston TX. Defferences between refactory anemia with excess in transfomation and acute myeloid leukemia. Blood,2000,96(1) :372-373.
2Harris NL Jaffe ES,Diebold J,et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue:Report of the clinical advisory committee meeting Airlie house, Virginia,November 1997,J Clin Oncology,1999,17(12) :3835-3849.
3卢兴国主编.现代血液形态学理论与实践.上海:上海科学技术出版社,2003:164-169.
4Bennett JM. World Health Organization classification of the acute leukemias and myelodysplastic syndromes. Int J Hematol,2000,72(2) :131-133.
2Harris, NL Jaffe ES,Diebold J,et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: Report of the clinical advisory committee meeting-Airlie house,Virginia, November 1997[J]. J Clin Oncology, 1999,17 (12): 3835-3849.
3Jaffe ES, Harris NL, Ciebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: Aprogress report[J]. Am Soci Chn Pathol, 1999, 111 (Suppl):8-12.
4Jaffe ES, Harris NL, Ciebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: Aprogress report[J]. Am Soci Clin Pathol, 1999, 111 (Suppl 1 ):S8-S12.
5Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopietic and lynphoid tissues[M]. Lyon. IARC Pess,2001.12-156, 275-302.
6Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms[J]. Blood, 2002, 100 (7) : 2292-2302.
7Bennett JM. World Health Organization classification of the acute leukemias and myelodysplastic syndromes[J]. Int J Hematol, 2000, 72 (2): 131-133.
8Jaffe ES,Harris NL,Stein H,et al.Pathology and genetics of tumours of haematopietic and lynphoid tissues[ M ].Lyon:IARC Pess,2001.23-25,59-66,77,183-184.
9Kobatashi S,Maruta A,Yamamoto T,et al.Significance of micromegakaryocytes in philadelphia chromosome-positove acute lymphoblastic leukemia[ J ].Leukemia,2000,14:1328-1329.
10Jaffe ES,Harris NL,Stein H,et al.Pathology and genetics of tumours of haematopoietic and lymphoid tissues[]..2001
